|Articles|October 14, 2011
"What are the sources of widely used estrogen?"
Author(s)Judith A. Norris, RNP
Is a question, I am frequently asked, most women are unaware that estrogens are derived by animals or plants. So, here's the list I used with my patients:
Advertisement
Is a question, I am frequently asked, most women are unaware that estrogens are derived by animals or plants. So, here's the list I used with my patients:
Drug Name
Route
Yrs. FDA
Approved
for
Strength
Alora®
Transdermal
1
Menopausal syndrome
0.05 mg
0.075 mg
0.1mg
Climara®
Transdermal
1
Menopausal syndrome
0.05 mg
0.75 mg
.1 mg
Estrace®
Oral
Vaginal
20
10
Menopausal syndrome,
Osteoporosis and
Vaginal atrophy
0.5 mg
1.0 mg
2.0 mg
0.1% cream
Estroderm®
Transdermal
10
Menopausal syndrome
Osteoporosis
0.05 mg
0.1 mg
Estratab®
Oral
20
Menopausal Syndrome
Osteoporosis
0.3 mg
0.625 mg
1.25 mg
2.5mg
Estring®
Vaginal Ring
1
Vaginal Atrophy
5-10mg
FemPatch®
Transdermal
1
Menopausal syndrome
0.05 mg
0.1 mg
Menest®
Oral
20
Menopausal syndrome
0.3 mg
0.625 mg
1.25 mg
2.5 mg
Ogen®
Oral
40
Menopausal Syndrome
Osteoporosis
0.625mg
1.25 mg.
Ortho-est®
Oral
2
Menopausal Syndrome
0.625 mg
1.25 mg
Vivelle®
Transdermal
1
Menopausal Syndrome
0.037
0.050
.75
0.1mg
ANIMAL BASED ESTROGEN
Drug Name
Route
Yrs. FDA Approved
for
Strength
Premarin®
Oral
50
Menopausal syndrome,
Osteoporosis
0.3 mg
0.625 mg
0.9 mg
1.25 mg
2.5 mg
ESTROGEN/PROGESTERONE COMBINATIONS
Drug Name
Route
Yrs. FDA
Approved
for
Strength
CombiPatch®
Transdermal
1
Menopausal Syndrome
0.05 mg estradiol
0.14 mg norethindrone
Prempro®
Oral
5
Menopausal Syndrome,
Osteoporosis
0.625 mg premarin
2.5 mg cycrin continous
Premphase®
Oral
5
Menopausal Syndrome,
Osteoporosis
0.625 mg premarin
5 mg cycrin sequential
ESTROGEN/ANDROGEN COMBINATIONS
Drug Name
Route
Yrs. FDA
Approved
for
Strength
Estratest®
Oral
5
Menopausal Syndrome,
Osteoporosis
1.25/2.5 mg
Estratest HS®
Oral
5
Menopausal Syndrome,
Osteoporosis
0.625/1.25 mg
References:
OBGYN.net © 1999 Judith A. Norris, Ob-Gyn, RNP, OBGYN.net Editorial Advisor
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
New guidelines on menopause and perimenopause management released
2
New insights on hormone therapy and autoimmune disease risk, with Xuezhi Daniel Jiang, MD, PhD
3
Addressing the emotional toll of infertility
4
Regina Castaneda, MD, on how hormone therapy may influence weight loss outcomes with tirzepatide
5
